Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 5
2006 2
2007 7
2008 6
2009 4
2010 5
2011 5
2012 5
2013 8
2014 6
2015 7
2016 10
2017 14
2018 11
2019 15
2020 11
2021 18
2022 26
2023 13
2024 15
2025 16
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Results by year

Filters applied: . Clear all
Page 1
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.
Taïeb D, Wanna GB, Ahmad M, Lussey-Lepoutre C, Perrier ND, Nölting S, Amar L, Timmers HJLM, Schwam ZG, Estrera AL, Lim M, Pollom EL, Vitzthum L, Bourdeau I, Casey RT, Castinetti F, Clifton-Bligh R, Corssmit EPM, de Krijger RR, Del Rivero J, Eisenhofer G, Ghayee HK, Gimenez-Roqueplo AP, Grossman A, Imperiale A, Jansen JC, Jha A, Kerstens MN, Kunst HPM, Liu JK, Maher ER, Marchioni D, Mercado-Asis LB, Mete O, Naruse M, Nilubol N, Pandit-Taskar N, Sebag F, Tanabe A, Widimsky J, Meuter L, Lenders JWM, Pacak K. Taïeb D, et al. Among authors: pandit taskar n. Lancet Diabetes Endocrinol. 2023 May;11(5):345-361. doi: 10.1016/S2213-8587(23)00038-4. Epub 2023 Mar 31. Lancet Diabetes Endocrinol. 2023. PMID: 37011647 Free PMC article. Review.
[89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.
Shuch B, Pantuck AJ, Bernhard JC, Morris MA, Master V, Scott AM, van Praet C, Bailly C, Önal B, Aksoy T, Merkx R, Schuster DM, Lee ST, Pandit-Taskar N, Fan AC, Allman P, Schmidt K, Tauchmanova L, Wheatcroft M, Behrenbruch C, Hayward CRW, Mulders P. Shuch B, et al. Among authors: pandit taskar n. Lancet Oncol. 2024 Oct;25(10):1277-1287. doi: 10.1016/S1470-2045(24)00402-9. Epub 2024 Sep 10. Lancet Oncol. 2024. PMID: 39270701 Free article. Clinical Trial.
Ovarian cancer.
Mironov S, Akin O, Pandit-Taskar N, Hann LE. Mironov S, et al. Among authors: pandit taskar n. Radiol Clin North Am. 2007 Jan;45(1):149-66. doi: 10.1016/j.rcl.2006.10.012. Radiol Clin North Am. 2007. PMID: 17157627 Review.
CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody.
Farwell MD, Gamache RF, Babazada H, Hellmann MD, Harding JJ, Korn R, Mascioni A, Le W, Wilson I, Gordon MS, Wu AM, Ulaner GA, Wolchok JD, Postow MA, Pandit-Taskar N. Farwell MD, et al. Among authors: pandit taskar n. J Nucl Med. 2022 May;63(5):720-726. doi: 10.2967/jnumed.121.262485. Epub 2021 Aug 19. J Nucl Med. 2022. PMID: 34413145 Free PMC article. Clinical Trial.
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.
Taïeb D, Hicks RJ, Hindié E, Guillet BA, Avram A, Ghedini P, Timmers HJ, Scott AT, Elojeimy S, Rubello D, Virgolini IJ, Fanti S, Balogova S, Pandit-Taskar N, Pacak K. Taïeb D, et al. Among authors: pandit taskar n. Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2112-2137. doi: 10.1007/s00259-019-04398-1. Epub 2019 Jun 29. Eur J Nucl Med Mol Imaging. 2019. PMID: 31254038 Free PMC article.
Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy.
Grkovski M, Krebs SS, O'Donoghue JA, Kuten J, Mauguen A, Shobeiri P, Lafontaine D, Thor M, Augensen F, Fox JJ, Pandit-Taskar N, Dunphy MP, Bodei L, Humm JL, Schöder H. Grkovski M, et al. Among authors: pandit taskar n. J Nucl Med. 2025 Oct 1;66(10):1622-1630. doi: 10.2967/jnumed.125.270170. J Nucl Med. 2025. PMID: 40774698 Free PMC article.
Targeted Radiopharmaceutical Therapy for Bone Metastases.
Mahajan S, Gavane S, Pandit-Taskar N. Mahajan S, et al. Among authors: pandit taskar n. Semin Nucl Med. 2024 Jul;54(4):497-512. doi: 10.1053/j.semnuclmed.2024.05.006. Epub 2024 Jun 26. Semin Nucl Med. 2024. PMID: 38937221 Review.
FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients.
McGale J, Khurana S, Howell H, Nakhla A, Roa T, Doshi P, Shirini D, Huang A, Duong P, Backhaus P, Liao M, Kaur H, Fontani AM, Hung I, Pandit-Taskar N, Haberkorn U, Gulati A, Naim A, Sinigaglia M, Bebawy M, Girard A, Seban RD, Dercle L. McGale J, et al. Among authors: pandit taskar n. Clin Nucl Med. 2025 Mar 1;50(3):e138-e145. doi: 10.1097/RLU.0000000000005617. Epub 2025 Jan 9. Clin Nucl Med. 2025. PMID: 39780367 Review.
181 results